Importance:
There is an ongoing debate about whether electronic cigarettes (e-cigarettes) are the solution to the tobacco epidemic or a new public health threat. Large representative studies are needed to study e-cigarette use in the general population, but hardly any have been published.
Objectives:
To estimate the prevalence of e-cigarette use and to investigate the association of e-cigarette use with smoking habits, demographic factors, and respiratory symptoms.
Design, Setting, And Participants:
Cross-sectional, population-based study of random samples of the population, performed within the Obstructive Lung Disease in Northern Sweden (OLIN) study and West Sweden Asthma Study (WSAS). The same validated questionnaire including identical questions was used in OLIN and WSAS. In 2016, OLIN and WSAS conducted postal questionnaire surveys in random samples of adults aged 20 to 75 years. In OLIN, 6519 participated (response rate, 56.4%); in WSAS, 23 753 participated (response rate, 50.1%).
Main Outcomes And Measures:
Electronic cigarette use, smoking habits, and respiratory symptoms.
Results:
Of 30 272 participants (16 325 women [53.9%]), 3897 (12.9%) were aged 20 to 29 years; 4242 (14.0%), 30 to 39 years; 5082 (16.8%), 40 to 49 years; 6052 (20.0%), 50 to 59 years; 6628 (21.9%), 60 to 69 years; and 4371 (14.4%), 70 to 75 years. The number of current smokers was 3694 (12.3%), and 7305 (24.4%) were former smokers. The number of e-cigarette users was 529 (2.0%), and e-cigarette use was more common among men (275 of 12 347 [2.2%; 95% CI, 2.0%-2.5%]) than women (254 of 14 022 [1.8%; 95% CI, 1.6%-2.0%]). Among current smokers, 350 of 3566 (9.8%; 95% CI, 8.8%-10.8%) used e-cigarettes compared with 79 of 6875 (1.1%; 95% CI, 0.9%-1.3%) in former smokers and 96 of 15 832 (0.6%; 95% CI, 0.5%-0.7%) in nonsmokers (P < .001). Among e-cigarette users who answered the survey question about cigarette-smoking habits (n = 525), 350 (66.7%; 95% CI, 62.7%-70.7%) were current smokers, 79 (15.0%; 95% CI, 11.9%-18.1%) were former smokers, and 96 (18.3%; 95% CI, 15.0%-21.6%) were nonsmokers (P < .001 for trend). In a regression analysis, e-cigarette use was associated with male sex (odds ratio [OR], 1.35; 95% CI, 1.12-1.62); age groups 20 to 29 years (OR, 2.77; 95% CI, 1.90-4.05), 30 to 39 years (OR, 2.27; 95% CI, 1.53-3.36), 40 to 49 years (OR, 1.65; 95% CI, 1.11-2.44), and 50 to 59 years (OR, 1.47; 95% CI, 1.01-2.12); educational level at primary school (OR, 1.99; 95% CI, 1.51-2.64) and upper secondary school (OR, 1.57; 95% CI, 1.25-1.96); former smoking (OR, 2.37; 95% CI, 1.73-3.24); and current smoking (OR, 18.10; 95% CI, 14.19-23.09). All respiratory symptoms were most common among dual users and former smokers and nonsmokers who used e-cigarettes.
Conclusions And Relevance:
Use of e-cigarettes was most common among smokers, and dual users had the highest prevalence of respiratory symptoms. On a population level, this study indicates that the present use of e-cigarettes does not adequately serve as a smoking cessation tool.
Citing Articles
Functionally important respiratory symptoms and continued cigarette use versus e-cigarette switching: population assessment of tobacco and health study waves 2-6.
Sargent J, Lauten K, Edwards K, Tanski S, MacKenzie T, Paulin L
EClinicalMedicine. 2025; 79:102951.
PMID: 39968205
PMC: 11833018.
DOI: 10.1016/j.eclinm.2024.102951.
Estimating the association between cigarette and e-cigarette use patterns and SARS-CoV-2 negative conversion time: retrospective online survey in China.
Xie Y, Li Y, Su Z, Han X, Liu Z, Huang Z
BMC Infect Dis. 2025; 25(1):161.
PMID: 39901130
PMC: 11792595.
DOI: 10.1186/s12879-025-10545-x.
Longitudinal association between e-cigarette use and respiratory symptoms among US adults: Findings from the Population Assessment of Tobacco and Health Study Waves 4-5.
Karey E, Xu S, He P, Niaura R, Cleland C, Stevens E
PLoS One. 2024; 19(2):e0299834.
PMID: 38421978
PMC: 10903800.
DOI: 10.1371/journal.pone.0299834.
Population-Based Disease Odds for E-Cigarettes and Dual Use versus Cigarettes.
Glantz S, Nguyen N, Oliveira da Silva A
NEJM Evid. 2024; 3(3):EVIDoa2300229.
PMID: 38411454
PMC: 11562742.
DOI: 10.1056/EVIDoa2300229.
Electronic cigarette use in relation to changes in smoking status and respiratory symptoms.
Hedman L, Lyytinen G, Backman H, Lundback M, Stridsman C, Lindberg A
Tob Induc Dis. 2024; 22.
PMID: 38259663
PMC: 10801701.
DOI: 10.18332/tid/176949.
Sex-specific lung inflammation and mitochondrial damage in a model of electronic cigarette exposure in asthma.
Song M, Kim J, Gorr M, Miller R, Karpurapu M, Nguyen J
Am J Physiol Lung Cell Mol Physiol. 2023; 325(5):L568-L579.
PMID: 37697923
PMC: 11068405.
DOI: 10.1152/ajplung.00033.2023.
Heated Tobacco Products: Insights into Composition and Toxicity.
Upadhyay S, Rahman M, Johanson G, Palmberg L, Ganguly K
Toxics. 2023; 11(8).
PMID: 37624172
PMC: 10459283.
DOI: 10.3390/toxics11080667.
[Positioning Document of Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) on Tobacco Harm Reduction Strategies].
Jimenez Ruiz C, Solano-Reina S, de Higes-Martinez E, Cabrera-Cesar E, Sandoval-Contreras R, de Granda-Orive J
Open Respir Arch. 2023; 4(2):100175.
PMID: 37497325
PMC: 10369613.
DOI: 10.1016/j.opresp.2022.100175.
Assessing tobacco use in Swedish young adults from self-report and urinary cotinine: a validation study using the BAMSE birth cohort.
Zettergren A, Sompa S, Palmberg L, Ljungman P, Pershagen G, Andersson N
BMJ Open. 2023; 13(7):e072582.
PMID: 37438074
PMC: 10347476.
DOI: 10.1136/bmjopen-2023-072582.
The spread of heated tobacco product (HTP) use across various subgroups during 2015-16 and 2017-18 in Japan.
Hori A, Tabuchi T, Kunugita N
Environ Health Prev Med. 2023; 28:5.
PMID: 36653145
PMC: 9884561.
DOI: 10.1265/ehpm.22-00219.
The E-cigarette or Vaping Product Use-Associated Lung Injury Epidemic: Pathogenesis, Management, and Future Directions: An Official American Thoracic Society Workshop Report.
Rebuli M, Rose J, Noel A, Croft D, Benowitz N, Cohen A
Ann Am Thorac Soc. 2022; 20(1):1-17.
PMID: 36584985
PMC: 9819258.
DOI: 10.1513/AnnalsATS.202209-796ST.
Tobacco use profiles by respiratory disorder status for adults in the wave 1-wave 4 population assessment of tobacco and health (PATH) study.
Cordova J, Pfeiffer R, Choi K, Grana Mayne R, Baker L, Bachand J
Prev Med Rep. 2022; 30:102016.
PMID: 36325251
PMC: 9619025.
DOI: 10.1016/j.pmedr.2022.102016.
The Health Effects of Real-World Dual Use of Electronic and Conventional Cigarettes versus the Health Effects of Exclusive Smoking of Conventional Cigarettes: A Systematic Review.
Pisinger C, Bergman Rasmussen S
Int J Environ Res Public Health. 2022; 19(20).
PMID: 36294263
PMC: 9603628.
DOI: 10.3390/ijerph192013687.
Chronic health effects associated with electronic cigarette use: A systematic review.
Wasfi R, Bang F, de Groh M, Champagne A, Han A, Lang J
Front Public Health. 2022; 10:959622.
PMID: 36276349
PMC: 9584749.
DOI: 10.3389/fpubh.2022.959622.
Electronic Cigarettes: A Narrative Review and Cohort Study of Electronic Cigarette Users in the Otolaryngology Clinic.
Debbaneh P, Dhir S, Anderson M, Rivero A
Perm J. 2022; 26(4):85-93.
PMID: 36184759
PMC: 9761286.
DOI: 10.7812/TPP/22.009.
Transitions between tobacco products: Correlates of changes in cigarette smoking and e-cigarette use among exclusive adult smokers and dual users in Mexico.
Gallegos-Carrillo K, Barrientos-Gutierrez I, Arillo-Santillan E, Rodriguez-Bolanos R, Cruz-Jimenez L, Desiree V
Prev Med Rep. 2022; 29:101869.
PMID: 35911576
PMC: 9326312.
DOI: 10.1016/j.pmedr.2022.101869.
Alpha7 nicotinic acetylcholine receptor mediates chronic nicotine inhalation-induced cardiopulmonary dysfunction.
Whitehead A, Fried N, Li Z, Neelamegam K, Pearson C, LaPenna K
Clin Sci (Lond). 2022; 136(12):973-987.
PMID: 35678315
PMC: 10199464.
DOI: 10.1042/CS20220083.
"When I Don't Have a Cigarette It's Helpful, but It Really Don't Satisfy:" Qualitative Study of Electronic Nicotine Delivery Systems (ENDS) Use among Low-Income Smokers.
Spears C, Jones D, Cottrell-Daniels C, Elahi H, Strosnider C, Luong J
Int J Environ Res Public Health. 2022; 19(3).
PMID: 35162181
PMC: 8834368.
DOI: 10.3390/ijerph19031157.
Neurobiological Mechanisms of Nicotine Reward and Aversion.
Wills L, Ables J, Braunscheidel K, Caligiuri S, Elayouby K, Fillinger C
Pharmacol Rev. 2022; 74(1):271-310.
PMID: 35017179
PMC: 11060337.
DOI: 10.1124/pharmrev.121.000299.
Electronic Cigarette Use in 12 European Countries: Results From the TackSHS Survey.
Gallus S, Lugo A, Stival C, Cerrai S, Clancy L, Filippidis F
J Epidemiol. 2021; 33(6):276-284.
PMID: 34776500
PMC: 10165220.
DOI: 10.2188/jea.JE20210329.